ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
…, A Gonzalez, R Fang, EJ Mark, JM Batten… - Journal of clinical …, 2012 - ascopubs.org
Purpose Chromosomal rearrangements involving the ROS1 receptor tyrosine kinase gene
have recently been described in a subset of non–small-cell lung cancers (NSCLCs). Because …
have recently been described in a subset of non–small-cell lung cancers (NSCLCs). Because …
[HTML][HTML] Clinical sensitivity and interpretation of PCR and serological COVID‐19 diagnostics for patients presenting to the hospital
…, LL Ritterhouse, SE Turbett, J Batten… - The FASEB …, 2020 - ncbi.nlm.nih.gov
The diagnosis of COVID‐19 requires integration of clinical and laboratory data. Severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) diagnostic assays play a central role in …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) diagnostic assays play a central role in …
IDH2 Mutations Define a Unique Subtype of Breast Cancer with Altered Nuclear Polarity
…, GM Baker, KS Cole, A Von Deimling, JM Batten… - Cancer research, 2016 - AACR
Solid papillary carcinoma with reverse polarity (SPCRP) is a rare breast cancer subtype with
an obscure etiology. In this study, we sought to describe its unique histopathologic features …
an obscure etiology. In this study, we sought to describe its unique histopathologic features …
Recurrent chromosomal copy number alterations in sporadic chordomas
The molecular events in chordoma pathogenesis have not been fully delineated, particularly
with respect to copy number changes. Understanding copy number alterations in chordoma …
with respect to copy number changes. Understanding copy number alterations in chordoma …
Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas
…, BM Wildemore, A Ganguly, J Batten… - The Journal of Molecular …, 2009 - Elsevier
Lynch syndrome is caused by germline mutations in DNA mismatch repair (MMR) genes.
Both microsatellite instability (MSI) testing and immunohistochemical analyses (IHC) of colon …
Both microsatellite instability (MSI) testing and immunohistochemical analyses (IHC) of colon …
Detection of novel actionable genetic changes in salivary duct carcinoma helps direct patient treatment
…, AK Cosper, K Bergethon, VL Scialabba, JM Batten… - Clinical cancer …, 2013 - AACR
Purpose: Salivary duct carcinomas (SDC) are a rare and aggressive subtype of salivary gland
cancers for which cytotoxic chemotherapy has limited efficacy. We investigated whether …
cancers for which cytotoxic chemotherapy has limited efficacy. We investigated whether …
DMD genomic deletions characterize a subset of progressive/higher-grade meningiomas with poor outcome
…, BM Kuter, MS Bertalan, JJ Miller, JM Batten… - Acta …, 2018 - Springer
Progressive meningiomas that have failed surgery and radiation have a poor prognosis and
no standard therapy. While meningiomas are more common in females overall, progressive …
no standard therapy. While meningiomas are more common in females overall, progressive …
[HTML][HTML] Next-generation sequencing and fluorescence in situ hybridization have comparable performance characteristics in the analysis of pancreaticobiliary …
Cytological evaluation of pancreatic or biliary duct brushings is a specific, but insensitive,
test for malignancy. We compared adjunctive molecular testing with next-generation …
test for malignancy. We compared adjunctive molecular testing with next-generation …
Genotype-targeted local therapy of glioma
…, JM Francis, ML Rinne, JM Batten… - Proceedings of the …, 2018 - National Acad Sciences
Aggressive neurosurgical resection to achieve sustained local control is essential for
prolonging survival in patients with lower-grade glioma. However, progression in many of these …
prolonging survival in patients with lower-grade glioma. However, progression in many of these …
Clinical Utility of Rapid EGFR Genotyping in Advanced Lung Cancer
…, JJ Lin, SR Digumarthy, JM Batten… - JCO precision …, 2018 - ascopubs.org
Purpose Targeted therapy is the cornerstone of treatment of advanced EGFR-mutant non–small-cell
lung cancer (NSCLC). Next-generation sequencing (NGS), the preferred method for …
lung cancer (NSCLC). Next-generation sequencing (NGS), the preferred method for …